Waisman Biomanufacturing is an industry–academia hybrid CDMO with facilities, equipment, and quality systems to scale up processes from the benchtop to large-scale manufacturing. Since its inception in 2001, the company has manufactured hundreds of clinical-grade products and has earned a reputation as a strategic partner for cost-effective and timely delivery. With in-depth experience in manufacturing a wide range of biotherapeutics for human clinical trials — including gene therapeutics, cell therapeutics, vaccines, and recombinant proteins — the company is well situated to move all therapy types into clinical trials. Based in Madison, Wisconsin, Waisman Biomanufacturing's multi-product biotechnology manufacturing facilities bridge the gap between discovery and therapy.